Dr. Linda Shore-Lesserson
, in her prospective study of cardiac surgery, showed a reduction in postoperative transfusion incidence of non-RBC blood products from 25% in the standard coagulation test-guided group to 5.6% in the TEG®-guided group.
<<
Back
|
Next
>>
For further assistance in North America, call 1-800-GET-A-TEG / 1-847-588-0453
Haemonetics Corp.
|
Contact Us
|
Feedback
|
Events
COPYRIGHT © 1998-2007, 2011 Haemonetics Corporation. All rights reserved.
